May 18, 2026
3 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
Pegtarazimod improves oxygen use, inflammatory biomarkers in acute COPD exacerbation
ORLANDO — Among hospitalized adults with acute exacerbation of COPD, pegtarazimod improved oxygen utilization and inflammatory biomarkers, according to phase 2a data.These findings on pegtarazimod (RLS-0071), “a dual-acting, anti-inflammatory peptide that inhibits the classical pathway of complement and neutrophil inflammatory effectors myeloperoxidase (MPO) and neutrophil
1,062 words~5 min read
